Luciana Gambirasio Souza’s Post

Speaking highly of Pharma Meeting Brazil might seem biased, but we can’t deny it: this is an event that delivers results! Our own experience proves it. We were looking for a partner to collaborate on our editorial line, someone who deeply understood the pharmaceutical industry and could create relevant content on strategic partnerships. Finding that person seemed complicated, but the solution came from where we least expected it. During the May 2024 edition, in a conversation with our client, Dr. Fisiologia, we discovered incredible synergies! This spontaneous encounter turned into an amazing collaboration, proving that networking at Pharma Meeting Brazil goes beyond simple connections — it generates real and productive partnerships. The proof of this result is the publication "Collabs in Pharma", which offers a complete overview of alliances in the pharmaceutical industry, from research to commercialization. "Collabs in Pharma" will be available on September 6th.

In this episode of Humanscience, we have the brilliant Norberto Prestes. Currently working as the Executive President of ABIQUIFI (Brazilian Association of the Pharmaceutical Inputs Industry), Norberto is a key figure in promoting the pharmaceutical inputs sector in Brazil. With vast market experience, Norberto has been actively working to strengthen the national production chain and enhance the sector's global competitiveness, as well as fostering innovations and strategic partnerships. His leadership is recognized for driving the sustainable development of Brazil's pharmaceutical industry. Once again, it was an honor to talk with him about the future of scientific research in Brazil. #HumanScience is an interview series focused on showcasing the people behind impactful scientific projects. #Sthorm #FindTheOthers #OneHealth #ScalingResearch

📢 Last week, we launched the State of the Discovery Nation 2024 report, in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry. Download here: https://hubs.li/Q02x3D3L0 The State of the Discovery Nation 2024 examines the sector’s challenges. It shows what is needed to secure a rich medicines pipeline and build on the UK’s global leadership in #LifeSciences. This includes: ---▶️ Creating strong partnerships with translational experts, who can take early-stage discoveries through to late-stage clinical development so #SMEs can de-risk assets for investment wherever they are in the UK ---▶️ Providing high-quality #laboratory facilities and incubator spaces for companies at all stages of maturity ---▶️ Make funds available, visible and accessible to support SMEs. Leverage private/public initiatives to co-develop pipelines of high-quality #FitToFund companies. In partnership with: Medicines Discovery Catapult | BioIndustry Association (BIA) | The Association of the British Pharmaceutical Industry (ABPI) #DrugDiscovery #SoDN2024 #Collaboration #SME

  Thrilled to be speaking at BIOPLUS-INTERPHEX KOREA (BIX) in Seoul this July! I look forward to discussing with the panel on Europe’s regulatory landscape for clinical trials, how new regulations are shaping the industry, and the opportunities in the region.  Let’s connect at BIX to explore regulatory strategies together!   #BIXKorea2024 #ClinicalTrialsEurope #RegulatoryAffairs 

New report! 🔊 This week, Medicines Discovery Catapult, BioIndustry Association (BIA) and The Association of the British Pharmaceutical Industry (ABPI) have released The State of the Discovery Nation 2024 Report.   The report takes an in-depth look at the impact of the economy for companies in the life sciences sector, identifying key challenges and exploring the steps needed to break down these barriers to continue growing the UK medicines discovery pipeline 🔎   Prof. Chris Molloy, CEO of Medicines Discovery Catapult, said: “It is not enough to ask investors to simply become more comfortable with high-risk investments. We need to de-risk the innovation as much as we can.”   Discover more below 👇🏻

Customized Reports: Spain's Gateway to Global Pharma Intelligence Spain is harnessing the power of customized reports to leapfrog into global pharmaceutical leadership: • Local Insights, Global Impact: Leveraging unique Spanish market data to inform international strategies. •Collaborative Research: Spain's role in fostering global pharmaceutical research collaborations through data sharing. • Innovation Ecosystem: Supporting Spain's burgeoning biotech landscape with targeted, data-driven insights. #SpainFarma #CustomizedReports #MENA

📢Exciting News! Biomapas CEO, János Filakovský, is attending and presenting at BIOPLUS-INTERPHEX KOREA (BIX) this July in Seoul! Janos will speak on the panel, ‘Regulatory Affairs for Clinical Trials in Europe’, covering Europe’s regulatory advantages, and new regulations introduced, aiming to further streamline clinical trials approval/authorisation process within the EU market.⚖️ The panel will discuss how Europe’s advanced clinical trial infrastructure and reasonable costs are making it an ideal destination for clinical trials. The session will explore the impact of new regulations, the competitive advantages Europe offers, and the financial incentives available.📈 BIX is a premier biopharmaceutical exhibition offering keynote sessions, conferences, and networking opportunities. Janos brings his extensive expertise in clinical research, regulatory compliance, and strategic growth into this dynamic event. Join Janos for a dive into the future of clinical trials in Europe. Don't miss the chance to connect and gain valuable insights! ✨Learn more about the session here: https://bit.ly/3RJ3mYU #BIXKorea2024 #Biopharmaceuticals #RegulatoryAffairs #LithuaniaCRO #KoreaBIO 

🚀 **Exciting News from Barcelona!** 🚀 Our **Market Study Task Force** gathered in Barcelona to dive into the data from our association members. We're gearing up to publish our **Market Study 2024** in the coming months. 📊 This study is a **crucial tool** for: - **Understanding** the contributions and impact of the generic and value-added pharmaceutical industry in Europe 🌍 - **Identifying** the main challenges we face 🛠️ - **Raising** our voice to key decision-makers and organizations in Europe 🗣️ Together, we're shaping the future of healthcare in Europe! 💪💊  #Generics #Innovation #AnimalHealth #AccesforVeterinarMedicines

Spain's Pioneering Role in Advanced Drug Molecules Spain is at the forefront of integrating advanced drug molecules into healthcare, showcasing: • Innovative Research Hubs: Spain's investment in biotech research centers is accelerating the development of groundbreaking drug molecules. • Collaborative Ecosystem: Strong partnerships between academia, industry, and government are driving Spain's success in pharmaceutical innovations. • Global Impact: Spanish pharmaceutical advancements are not only transforming local healthcare but also making significant contributions to global medicine. #GlobalHealthcare #SpainPharmaceuticals #MENA #DrugMolecules #Spain

Have you done your homework on market analysis of your product? Come and learn how Citeline can help you.